TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 135 filers reported holding TG THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $781,000 | +97.7% | 70,350 | 0.0% | 0.05% | +75.9% |
| Q3 2019 | $395,000 | -35.1% | 70,350 | 0.0% | 0.03% | -39.6% |
| Q2 2019 | $609,000 | +7.6% | 70,350 | 0.0% | 0.05% | +2.1% |
| Q1 2019 | $566,000 | +205.9% | 70,350 | +56.3% | 0.05% | +176.5% |
| Q4 2018 | $185,000 | -52.9% | 45,000 | -35.9% | 0.02% | -55.3% |
| Q3 2018 | $393,000 | -57.4% | 70,200 | 0.0% | 0.04% | -60.0% |
| Q2 2018 | $923,000 | – | 70,200 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |